Although low Bach2 expression was reported to be associated with high leukemic cell proliferation, unfavorable clinical features, and poor clinical outcome in acute lymphoblastic leukemia (ALL) [25, 26], there are only a few reports about the role of Bach2 in solid tumors. Here, BACH2 is linked to acute lymphoblastic leukemia.